Skip to main content

Class Action Alleges Valsartan As An Unapproved Drug

Class Action Alleges Valsartan As An Unapproved Drug

Class Action Alleges Valsartan As An Unapproved Drug

Introduction

The valsartan class action lawsuit has alleged that the recalled generic versions of the blood pressure medication distributed in recent years should be considered as an unapproved drug due to the presence of carcinogenic impurities.

According to a complaint filed last week in the U.S. District Court for the District of New Jersey, the plaintiff has alleged that the valsartan manufacturers illegally sold contaminated drugs and falsely advertised them as generic valsartan equivalents, cheating hundreds of thousands of consumers and putting their health at risk. The allegations were on behalf of all Florida residents who purchased recalled generic valsartan products manufactured and distributed by Zhejiang Huahai Pharmaceutical Co., Ltd., Solco Healthcare U.S., and Prinston Pharmaceutical, Inc., who are all defendants in the claim.

There are currently 10 class action lawsuits and one individual action pending in District Courts across the U.S. against Valsartan. Valsartan claims are consolidated under MDL No. 2875 (In re Valsartan Products Liability Litigation) in the United States District Court, District of New Jersey, presided by Judge Robert B. Kugler, U.S.D.J and Hon. Joel Schneider, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.